Invest now

Bharat Immunologicals & Biologicals Corporation Ltd Cash Flow Annual

BSE: 524663 | NSE: - | ISIN: INE994B01014 | Sector: Biotechnology & Drugs
15.95 +0.20 (1.27%)Updated : 14 Aug 2026
Research on
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Issuance( Retirement)of Debt Net -7.6750.59-29.18-29.18
Net Changein Cash -3.363.420.580.58
Net Income/ Starting Line -22.85-9.69-14.20-14.20
Changesin Working Capital 27.02-37.7044.2144.21
Cashfrom Operating Activities 10.89-42.1234.0834.08
Cash Interest Paid 7.045.594.744.74
Cashfrom Financing Activities -14.7145.00-34.41-34.41
Depreciation/ Depletion 0.150.210.240.24
Other Investing Cash Flow Items Total 0.460.530.910.91
Capital Expenditures 0.000.000.000.00
period Type ----
Non- Cash Items 6.585.063.843.84
Financing Cash Flow Items -7.04-5.59-5.23-5.23
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities 0.460.530.910.91
*All figures in crores except per share values
Recommended For You
Trending Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)